| Literature DB >> 29628896 |
Bruna S de Alencar Silva1, Fábio S Lira2, Fabrício E Rossi3, Dionei Ramos4, Juliana S Uzeloto4, Ana P C F Freire4, Fabiano F de Lima4, Luís A Gobbo1, Ercy M C Ramos4.
Abstract
Background: Low-grade inflammation can be present in chronic obstructive pulmonary disease (COPD), which may affect the regulation of muscle protein and body metabolism. Regular exercise show improvement in muscle strength and dyspnea in patients with COPD, however, the response to training on inflammatory and metabolic disorders is unclear. In this study, we compared the effects of resistance training using weight machines and elastic resistance (bands and tubes) on the inflammatory and metabolic responses in patients with COPD.Entities:
Keywords: chronic obstructive pulmonary disease; inflammation; interleukins; metabolism; resistance training
Year: 2018 PMID: 29628896 PMCID: PMC5877487 DOI: 10.3389/fphys.2018.00262
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Acute and chronic blood analysis in baseline and after 12 weeks.
Figure 2Flow diagram.
Anthropometric data and spirometric indexes of the sample in baseline.
| Age (years) | 69.35 ± 8.97 | 64.88 ± 11.17 | 0.13 |
| BMI (Kg/m2) | 26.38 ± 4.65 | 27.12 ± 5.00 | 0.60 |
| FVC % predict | 72.48 ± 13.22 | 66.05 ± 13.97 | 0.12 |
| FEV1 % predict | 50.69 ± 16.67 | 45.40 ± 15.15 | 0.28 |
| FEV1/ FVC | 54.34 ± 12.86 | 55.01 ± 14.20 | 0.86 |
BMI, body mass index; Kg, Kilograms; FVC, Forced vital capacity; Pred, predicted; FEV.
Figure 3Analysis of inflammatory parameters (Δ%) in acute exercise session at baseline and 12 weeks after training protocol. Data expressed as mean and 95% confidence interval. (A) Interleukin 6, IL-6 (pg/mL); (B) Tumor necrosis factor-alfa, TNF-α (pg/mL); (C) Interleukin 10, IL-10 (pg/mL); (D) Interleukin 15, IL-15 (pg/mL). Post-0—Rest: difference between immediately post- exercise session and rest; Post-30—rest: difference between 30 min post- exercise and rest. Post-30—Post-0: difference between 30 min post- exercise and immediately post- exercise session. *Significant differences between conditions between acute exercise at baseline and after 12 weeks (bout 1 vs. bout 2); #Significant main effect of time (Rest, Post-0, and Post-30). In the comparisons between acute exercise at baseline and after 12 weeks of exercise training; EG: n = 24; MG: n = 11. Statistical test used: A Mauchly's test of sphericity was used to test this assumption, and a Greenhouse-Geisser correction was applied when necessary. A three-way analysis of variance were used to compare group (EG × MG), condition (baseline = bout 1 × after 12 weeks of training = bout 2) and time [Rest, immediately post-exercise (Post-0), and 30 min post- exercise (Post-30)] was conducted to verify the inflammatory and metabolic responses in the acute exercise sessions between groups. Finally, delta values was conducted (Immediately post-exercise minus Rest; 30 min post- exercise minus Rest and 30 min post- exercise minus Immediately post-exercise, all values were divided by rest and multiplied by 100 = Δ%).
Effects after 12-week training of peripheral muscle strength between EG (n = 24) and MG (n = 11).
| Elbow flexion (N) | EG | 13.77 ± 5.32 | 16.78 ± 6.09 | 0.53 | 3.01 [0.83 to 5.18] | Group | 0.09 | 3.02 | 0.08 | |
| 0.71 | Time | <0.01 | 8.64 | 0.21 | ||||||
| MG | 11.20 ± 4.87 | 13.54 ± 3.97 | 0.53 | 2.33 [−1.00 to 5.68] | Group × time | 0.71 | 0.13 | 0.01 | ||
| Knee extension (N) | EG | 30.01 ± 11.08 | 37.21 ± 12.85 | 0.60 | 7.20 [3.30 to 11.19] | Group | 0.05 | 4.27 | 0.11 | |
| 0.58 | Time | <0.01 | 14.25 | 0.30 | ||||||
| MG | 23.68 ± 8.72 | 29.04 ± 7.69 | 0.65 | 5.35 [−0.71 to 11.42] | Group × time | 0.58 | 0.31 | 0.01 |
N, newtons; EG, elastic group; MG, weight machine group. Data expressed as mean and standard deviation; Delta post-pre: difference between the initial and final evaluations of each group expressed as mean and 95% confidence interval.
Effects after 12-week training of inflammatory profile between EG (n = 24) and MG (n = 11).
| IL-6 (pg/ml) | EG | 2.41 ± 1.55 | 1.42 ± 1.04 | 0.76 | −0.91 [−1.80 to 0.03] | Group | 0.04 | 4.39 | 0.13 | |
| 0.48 | Time | <0.01 | 10.55 | 0.27 | ||||||
| MG | 3.90 ± 2.93 | 2.22 ± 1.80 | 0.71 | −1.66 [−3.91 to 0.58] | Group × time | 0.40 | 0.70 | 0.02 | ||
| TNF-α (pg/ml) | EG | 8.10 ± 10.83 | 4.17 ± 8.15 | 0.41 | −3.45 [−5.88 to −1.03] | Group | 0.31 | 1.05 | 0.03 | |
| 0.44 | Time | <0.01 | 10.55 | 0.28 | ||||||
| MG | 14.14 ± 20.18 | 6.90 ± 7.52 | 0.52 | −8.15 [−18.11 to 1.80] | Group × time | 0.34 | 0.94 | 0.03 | ||
| IL-10 (pg/ml) | EG | 1.64 ± 0.63 | 1.80 ± 1.47 | 0.15 | −0.09 [−0.56 to 0.75] | Group | 0.02 | 5.51 | 0.14 | |
| 0.06 | Time | 0.15 | 2.08 | 0.06 | ||||||
| MG | 3.35 ± 2.60 | 2.30 ± 1.60 | 0.50 | −1.05 [−2.19 to 0.09] | Group × time | 0.06 | 3.03 | 0.16 | ||
| IL-15 (pg/ml) | EG | 57.73 ± 33.12 | 42.75 ± 32.91 | 0.86 | −11.76 [−35.65 to 12.12] | Group | 0.10 | 2.80 | 0.07 | |
| 0.69 | Time | 0.03 | 4.88 | 0.12 | ||||||
| MG | 89.11 ± 100.30 | 65.80 ± 42.23 | 0.33 | −25.73 [−73.08 to 21.62] | Group × time | 0.63 | 0.23 | <0.01 | ||
| IL-10/TNF-α (pg/ml) | EG | 0.42 ± 0.34 | 2.67 ± 4.01 | 1.03 | 2.05 [−0.11 to 4.22] | Group | 0.17 | 1.16 | 0.08 | |
| 0.03 | Time | 0.10 | 2.79 | 0.09 | ||||||
| MG | 0.67 ± 0.68 | 0.63 ± 0.53 | 0.07 | −0.04 [−0.53 to 0.44] | Group × time | 0.09 | 3.03 | 0.10 |
IL-6, Interleukin-6; TNF-α, Tumor necrosis factor-alfa; IL-10, Interleukin-10; IL-15, Interleukin-15; IL-10/TNF-α, Interleukin-10/Tumor necrosis factor-alfa ratio. EG, elastic group; MG, weight machine group. Data expressed as mean and standard deviation; Delta post-pre: difference between the initial and final evaluations of each group expressed as mean and 95% confidence interval.
Effects post 12-week training of metabolic profile between EG (n = 24) and MG (n = 11).
| Glucose (mg/dL) | EG | 90.45 ± 14.80 | 81.51 ± 17.46 | 0.55 | −7.90 [−16.35 to 0.54] | Group | 0,22 | 1.5 | 0.07 | |
| 0.59 | Time | 0.01 | 6.93 | 0.17 | ||||||
| MG | 84.63 ± 26.95 | 71.13 ± 32.02 | 0.46 | −12.74 [−34.62 to 9.13] | Group × time | 0,59 | 0.28 | <0.01 | ||
| Total cholesterol (mg/dL) | EG | 108.37 ± 25.30 | 104.58 ± 14.34 | 0.19 | −5.58 [−15.68 to 4.52] | Group | 0.63 | 0.23 | <0.01 | |
| 0.88 | Time | 0,30 | 1.10 | 0.33 | ||||||
| MG | 104.84 ± 38.42 | 99.86 ± 32.85 | 0.14 | −3.32 [−22.55 to 15.90] | Group × time | 0,88 | 0.02 | <0.01 | ||
| Triacylglycerol (mg/dL) | EG | 154.17 ± 62.34 | 129.72 ± 40.32 | 0.48 | −23.87 [−43.66 to −4.08] | Group | 0,97 | <0.01 | 0.00 | |
| <0.01 | Time | 0.66 | 0.18 | <0.01 | ||||||
| MG | 132.31 ± 43.60 | 150.34 ± 52.30 | 0.38 | 9.99 [−8.71 to 28.71] | Group × time | <0.01 | 8.25 | <0.21 | ||
| HDL cholesterol (mg/dL) | EG | 58.44 ± 23.17 | 63.43 ± 17.25 | 0.40 [−8.81 to 9.62] | Group | 0.18 | 183 | 0.05 | ||
| 0.22 | Time | 0,92 | <0.01 | 0.00 | ||||||
| MG | 54.43 ± 21.90 | 50.12 ± 17.34 | 0.25 | −3.20 [−11.38 to 4.97] | Group × time | 0.22 | 1.53 | 0.04 | ||
| Albumin (mg/ml) | EG | 63.64 ± 16.83 | 62.56 ± 15.82 | 0.07 | −1.27 [−11.69 to 9.15] | Group | 0.52 | 0.40 | 0.01 | |
| 0.33 | Time | 0.24 | 1.43 | 0.04 | ||||||
| MG | 71.88 ± 31.23 | 61.25 ± 15.40 | 0,46 | −33.93 [−33.93 to 12.66] | Group × time | 0.33 | 0.95 | 0.03 | ||
| Total colesterol—HDL (mg/dl) | EG | 50.70 ± 39.87 | 40.94 ± 25.81 | 0.30 | −5.98 [−19.57 to 7.61] | Group | 0.68 | 0.16 | <0.01 | |
| 0.43 | Time | 0.36 | 0.82 | 0.02 | ||||||
| MG | 50.41 ± 33.95 | 49.74 ± 24.50 | 0.02 | −0.12 [−21.43 to 21.18] | Group × time | 0,43 | 0.63 | 0.01 |
EG, elastic group; MG, weight machine group;
p < 0.05 in compression between baseline and 12 weeks in EG. Data expressed as mean and standard deviation; Delta post-pre: difference between the initial and final evaluations of each group expressed as mean and 95% confidence interval.